TECHNOLOGY THAT PROTECTS YOUR VISION
Novar Myofix lenses are designed to support your child's visual development. Their peripheral defocus technology not only corrects myopia but also helps slow its progression. This provides greater protection for future eye health and reduces the risk of severe myopia in adulthood.
TIPS FOR CARING FOR YOUR CHILD'S VISION
Encourage a break from screens every 20 minutes.
Limit time spent using devices with blue-light-emitting screens.
Enable dark mode so white text can be read on a black background.
Increase text size on screens to help prevent eye strain.
Keep at least 30 cm between your child's eyes and the phone screen.
Encourage at least 2 hours of outdoor activity every day.
Remove digital devices at least 2 hours before bedtime.
Make sure indoor spaces have enough light.
WHAT IF PROTECTING YOUR CHILD'S EYE HEALTH STARTS WITH A VISIT TO THE DOCTOR?
Already diagnosed with myopia
If your child has already been diagnosed with myopia, what matters is not only how they see today, but how they will see tomorrow. An eye care professional can help you choose lenses that correct vision and control myopia progression, reducing the risk of severe myopia. Myofix is specifically designed to help slow childhood myopia progression with clinical support. Acting now makes a difference.
Myopia is just beginning
When myopia is detected early, much can be done to slow it in time. Consulting a specialist makes it possible to begin appropriate treatment with solutions such as Novar Myofix, which improves vision and helps control its progression. Prevention is also treatment.
A global solution for progressive myopia
Novar Myofix lenses are available across Latin America, Europe, Africa, and Asia, backed by the technical and operational support of our international network of certified laboratories.
THE SCIENCE BEHIND MYOFIX
Six-month results with defocus spectacles for myopia control in Argentina (Myofix Study)
Rafael Iribarren, Abel Szeps, Martin de Tomas, Gabriel Martin.
READ MORE
Axial length changes with simple defocus spectacles (SDS)
Rafael Iribarren, Abel Szeps, Liliana Laurencio, Martin de Tomas, Ricardo Impagliazzo, Gabriel Martin.
READ MORE
Full-day school hours and additional childhood classes may be associated with earlier myopia onset
Abel Szeps, Carla Lanca, Rafael Iribarren.
READ MORERECOMMENDED BY THOSE WHO KNOW BEST
“What has impressed me most so far is how easily children adapt to wearing them; they use them all day.”
Dra. Carla Lança Ophthalmologist
“Among these children, those with greater adherence to wearing Myofix glasses achieved an approximately 75% reduction in myopia progression.”
Dra Romina Quercia OphthalmologistADAPTATION GUARANTEE
NOVAR guarantees an excellent visual experience while you adapt to your lenses.
FREQUENTLY ASKED QUESTIONS
1. Why does my child have progressive myopia, and how long can it continue to increase?
Progressive myopia may be influenced by genetics and habits such as heavy screen use in poor lighting or limited time outdoors. It can continue to increase during childhood and adolescence. Novar Myofix helps control this progression and protect your child's vision early.
2. How serious can my child's myopia become if it keeps progressing?
Uncontrolled myopia can create everyday difficulties and increase the risk of eye problems in adulthood. Novar Myofix helps slow progression and reduce these risks to protect future eye health.
3. Is there a treatment that can truly slow or control this progression?
Yes. Novar Myofix is a lens specifically designed to control childhood myopia, supported by clinical studies. It not only corrects vision; it also helps slow myopia progression.
4. What can I do every day to help care for my child's vision?
Along with healthy habits—less screen time, good lighting, more time outdoors, and breaks during near work—ask an eye care professional about Novar Myofix treatment to support daily eye care.
HAVE A QUESTION? CONTACT US
References
1.
De Tomas M, Kotlik C, Szep S, Impagliazzo R, Iribarren R. New Spectacles for Myopia Control. Oftalmol Clin Exp. 2022; 15: 240–7.
2.
Iribarren R SA, Kotlik C, Laurencio L, De Tomas M, Impagliazzo R, Martin G. Short–Term Axial Length Changes in Myopic Eyes Induced by Defocus Spectacles for Myopia Control. Photonics 2023; 10: 668.
3.
Szep S A, Dankert S, Saracco G, Iribarren R. A pilot study of axial length changes associated with myopia control spectacles in subjects reading under mesopic conditions. Journal of AAPOS, 2024: 103857.
4.
De Tomas M, Szep S A, Martin G, Suarez JM, Atchison DA, Rozema JJ, Iribarren R. Retinal shadows produced by myopia control spectacles. Ophthalmic Physiol Opt 2024; 44(1):214–218. doi: 10.1111/opo.13228.
5.
Szep S A KC, Fernández Irigaray L, Saracco G, De Tomas M, Martin G, Iribarren R. Baseline data in the study on the tolerance and efficacy of peripheral defocus spectacles for the control of myopia progression in Argentina (Myofix Defocus Study). Oftalmol Clin Exp 2024; 17: 352–8.
6.
De Tomás M SA, Martín G, Saracco G, Lanca C, Iribarren R. Effect of vertex distance in the treatment area of myopia control spectacles. Oftalmol Clin Exp 2024; 17: e547–e53.
7.
Saracco G AM, De Tomás M, Martín G, Iribarren R. Development of a frame adaptation for myopia control spectacles. Oftalmol Clin Exp 2025; 18: e195–e201.
8.
Iribarren R SA, De Tomás M, Martín G. Six months results with defocus spectacles for myopia control in Argentina (Myofix trial). In: International Myopia Conference 2024, Sanya, China, 2024.
